Exhaled cytokines in systemic lupus erythematosus with lung involvement

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 4, 2013, Pages 141-148

  Nielepkowicz Goździńska, Agnieszka ^a   Fendler, Wojciech ^a   Robak, Ewa ^a   Kulczycka Siennicka, Lilianna ^a   Gorski, Paweł ^a   Pietras, Tadeusz ^a   Brzeziańska, Ewa ^a   Antczak, Adam ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Bronchoalveolar lavage fluid; Exhaled breath condensate; Interleukin 10; Interleukin 6; Systemic lupus erythematosus

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; ARTICLE; BREATHING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXHALED BREATH CONDENSATE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS; TOTAL LUNG CAPACITY;

ADULT; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PULMONARY FIBROSIS;

EID: 84879647417     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1676     Document Type: Article

References (33)

1. Kao AH, Sabatine JM, Manzi S. Lung disease in lupus. In: Wells AU, Denton CP, eds. Pulmonary involvement in systemic autoimmune diseases. Elsevier; 2004: 125-246.
2. du Bois RM, Wells AU. The lungs and connective tissue diseases. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA. Textbook of respiratory medicine. Elsevier Saunders; 2005: 1609-1633.
3. AbuShakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995; 1259-1264.
4. Cieślik P, Hrycek A, Kłuciński P. Vasculopathy and vasculitis in systemic lupus erythematosus. Pol Arch Med Wewn. 2008; 118: 57-63.
5. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus. The American College of Rheumatology Response Criteria for Systemic Lupus Erythematosus Clinical Trials. Arthritis & Rheumatism. Lippincott-Raven Publisher; 1999.
6. Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005; 19: 685-708.
7. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-338.
8. Wanger J, Clausen JL, Coates A,et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26: 511-522.
9. Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005; 26: 523-548.
10. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. British Thoracic Society Bronchoscopy Guidelines Committee, a Subcommittee of the Standards of Care Committee of the British Thoracic Society. Thorax. 2001; 56 (Suppl): i1-i21.
11. Suh CH, Kim HA. Cytokines and their receptors as biomarkers of systemic lupus erythematosus. Expert Rev Mol Diagn. 2008; 8: 189-198.
12. Mayberry JP, Primack SL, Müller NL. Thoracic manifestations of systemic autoimmune diseases: radiographic and high-resolution CT findings. Radiographics. 2000; 20: 1623-1635.
13. Al-Mutairi S, Al-Awadhi A, Raghupathy R, et al. Lupus patients with pulmonary involvement have a proinflammatory cytokines profile. Rheumatology Int. 2007; 7: 621-630.
14. Gröndal G, Gunnarsson I, Rönnelid J, et al. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 2000; 18: 565-570.
15. al-Janadi M, al-Dalaan A, al-Balla, et al. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis. J Clin Immunol. 1996; 16: 198-207.
16. Llorente L, Richaud-Patin Y, Fior R, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 1994; 37: 1647-1655.
17. Chun HY, Chung JW, Kim HA, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol. 2007; 27: 461-466.
18. Capper ER, Maskill JK, Gordon C, Blakemore AI. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology? Clin Exp Immunol. 2004; 138: 348-356.
19. Park YB, Lee SK, Kim DS, et al. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 1998; 16: 283-288.
20. Tyrrell-Price J, Lydyard PM, Isenberg DA. The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus. Clin Exp Immunol. 2001; 124: 118-125.
21. Gröndal G, Kristjansdottir H, Gunnlaugsdottir B, et al. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum. 1999; 42: 1649-1654.
22. Llorente L, Richaud-Patin Y, Garcia-Padilla C, et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 2000; 43: 1790-1800.
23. Cross JT, Benton HP. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Inflamm Res. 1999; 48: 255-261.
24. Smykał-Jankowiak K, Niemir ZI, Polcyn-Adamczak M. Do circulating antibodies against C1q reflect the activity of lupus nephritis? Pol Arch Med Wewn. 2011; 121: 287-295.
25. Yap DY, Lai KN. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol. 2010; 210: 365 083.
26. Davas EM, Tsirogianni A, Kappou I, et al. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol. 1999; 18: 17-22.
27. Sabry A, Sheashaa H, El-Husseini A, et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine. 2006; 35: 148-153.
28. Tsai CY, Wu TH, Yu CL, et al. Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron. 2000; 85: 207-214.
29. Hirohata S, Kanai Y, Mitsuo A, et al. Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. NPSLE Research Subcommittee. Clin Rheumatol. 2009; 28: 1319-1323.
30. Yoshio T, Masuyama JI, Kohda N, et al. Association of interleukin 6 release from endothelial cells and pulmonary hypertension in SLE. J Rheumatol. 1997; 24: 489-495.
31. Dean G, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis. 2000; 54: 243-251.
32. Urbankowski T, Hoser G, Domagała-Kulawik J. Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: association with smoking. Pol Arch Med Wewn. 2012; 122: 320-325.
33. Miyata M, Ito M, Sasajima T, et al. Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats. Chest. 2001; 119: 554-561.